000 03915nam a22003735i 4500
001 100142
003 DE-He213
005 20230110040206.0
007 cr nn 008mamaa
008 180618s2018 gw | s |||| 0|eng d
020 _a9783319776743
_9
024 7 _a10.1007/978-3-319-77674-3
_2doi
040 _aES-MaUEC
_bspa
050 4 _aRC582 2018 EB
245 1 0 _aManagement of Infections in the Immunocompromised Host
_cedited by Brahm H. Segal.
264 1 _aCham
_bSpringer International Publishing
_c2018
300 _a1 recurso en línea (XIV, 445 páginas 27 ilustraciones a color)
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
505 0 _a1.Phagocytes -- 2.T-cells -- 3.B cell Immunity -- 4.Complement -- 5.Antimicrobial peptides -- 6.Role of Deficits in Pathogen Recognition Receptors in Infection Susceptibility -- 7.Defects of Innate Immunity -- 8.T Cell Defects -- 9.Inflammatory Bowel Disease in Primary Immunodeficiencies -- 10.Infections in Cancer -- 11.Infections in Hematopoietic Stem Cell Transplant Recipients -- 12.Infections in Solid Organ Transplant Recipients -- 13.Infections in HIV infected patients -- 14.Infections in Patients with Autoimmune Diseases -- 15.Antibacterials and antifungals: The Challenges of Antibiotic-Resistant Infections in the Immunocompromised Host -- 16.Antiviral treatment and prophylaxis in immunocompromised hosts -- 17.Role of Immunoglobulin Therapy to Prevent and Treat Infections -- 18.Vaccination of Immunocompromised Patients -- 19..Stem Cell Transplantation for Primary Immunodeficiency -- 20.Specific Adoptive T-cell Therapy for Viral and Fungal Infections -- 21.Gene Therapy for Primary Immunodeficiencies.
520 3 _aThis book provides a comprehensive, state-of-the-art review of the concepts vital to a modern treatment of common and opportunistic infections in the immunocompromised host. Chapters are written by experts in the field, and include their views on gaps in the field and future directions of research. This book begins with an overview of the normally functioning immune system followed by a detailed discussion of the major primary immunodeficiencies. Specific chapters are dedicated to providing practical knowledge in the prevention and treatment of infections in specific immunocompromised patients, including those with cancer, transplant recipients, HIV infection, and autoimmune disorders. Emphasis is placed on diagnostic evaluation, antimicrobial selection that includes consideration of the threat of antimicrobial-resistant pathogens, and immunotherapy tailored to specific patients. Finally, dedicated chapters on stem cell transplantation for patients with primary immunodeficiencies, adoptive cellular immunotherapy, and gene therapy will provide readers with insight into these rapidly evolving and cutting edge therapies. Management of Infections in the Immunocompromised Host is a valuable resource for infectious diseases specialists, immunologists, oncologists, hematologists, general physicians, students, researchers, and all other working with immunocompromised patients.
650 7 _aEnfermedades inmunológicas
_9142010
_2embne
650 7 _aOncología
_2embne
_9139207
650 7 _aInmunodeficiencia
_9667061
_2embne
700 1 _aSegal, Brahm H.
_eeditor literario
_0http://id.loc.gov/authorities/names/n2012180412
_0http://viaf.org/viaf/224461940
776 0 8 _iEdición impresa:
_z9783319776729
776 0 8 _iEdición impresa:
_z9783319776736
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-77674-3
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
490 0 _aMedicine (Springer-11650)
988 _aSpringer_Medicine_2018
998 _b01/2019
_dz
_ea
_feng
_ggw
_h0
999 _c100142
_d100142
_x1